Bliss Aesthetics Raises $17.5M to Launch AI-Powered Cosmetic Surgery Platform

Bliss Aesthetics, a digital platform that uses artificial intelligence (AI) to connect patients with board-certified plastic surgeons, announced a $17.5 million seed funding round. The investment, led by Shine Capital with participation from Synchrony Ventures, Sheva Ventures, Point72 Ventures, and Cerca Partners, will support rapid expansion across the U.S.

Bliss leverages generative AI, Stable Diffusion, and computer vision to help patients visualize realistic aesthetic outcomes, find qualified providers, and explore financing—all in one platform. With the global aesthetic medicine market projected to reach $200 billion within a decade, Bliss aims to deliver smarter, more personalized experiences in a fragmented industry.

Since launching, Bliss has grown its provider network by 500% and is expanding into five new states. Clinics using the platform have seen patient conversion rates increase from 40% to 80%, driven by improved transparency and decision-making.

“This funding allows us to meet growing demand for intelligent, patient-first technology in aesthetic care,” Gal Yosef, Co-Founder and CEO of Bliss, said in a press release. “Bliss simplifies the journey for both patients and physicians, reducing friction while improving outcomes.”

Co-founder and Chief Medical Officer Dr. Michael Salzhauer, known as Dr. Miami, said, “Bliss empowers surgeons to deliver better results with less administrative burden. It’s a major step forward for the industry.”

Shine Capital’s Mo Koyfman called Bliss a “category-defining solution” for a fast-changing market. Synchrony’s Maran Nalluswami added that the platform aligns with their commitment to transparency and access in health and wellness financing.